Assessment of Tacrolimus Neurotoxicity Measured by Retinal OCT

• Published in: Transplantation proceedings 2022-01, Vol.54 (1), p.80-86
• Main Authors: Mousavi Ahmadian, Kazem, Serra Cabañas, Núria, Cordoba Herrera, Christian, Fayos de Arizon, Leonor, Perez Mir, Mónica, Guirado Perich, Lluís, Facundo Molas, Carme
• Format: Article
• Language: English
• Subjects: Humans; Renal Dialysis; Retina - diagnostic imaging; Retinal Ganglion Cells; Tacrolimus - adverse effects; Tomography, Optical Coherence
• ISSN: 0041-1345; 1873-2623
• DOI: 10.1016/j.transproceed.2021.10.013

Neurotoxicity secondary to anticalcineurinics is a prevalent side effect in transplant recipients. Optical coherence tomography (OCT) scans the central nervous system by direct access to the retina. OCT assesses central nervous system involvement by measuring the thickness of the retinal layers, especially the ganglion cell layer (GCL). The retinal scan divides the scanned area into affected and unaffected segments, which can be quantified for each eye. The aim of this study was to determine retinal GCL thickness by means of OCT, analyzing the proportion of affected segments in individuals exposed to tacrolimus compared with a control group. We evaluated 20 renal transplant recipients exposed to tacrolimus for ≥6 months. The number of affected segments in the GCL of the retina was quantified by OCT. The control group was drawn from the general population attending routine ophthalmologic checkups. Patients exposed to tacrolimus had a pathologic examination in 50% of cases compared with 20% in the control group (P < .044). Furthermore, among patients with an exposure time to tacrolimus >5 years, the examination was pathologic in 80% (P < .005). Linear regression analysis showed the presence of GCL segments with decreased thickness to be associated with the duration of exposure to tacrolimus (P = .036) and the time in dialysis before kidney transplant (P = .030). Although this is a preliminary study, OCT scanning could serve to detect the neurotoxic effect of tacrolimus on the retinal GCL and central nervous system in renal transplant recipients.